Overview on the Causes and Management of Neonatal Meningitis

References (55)

1. 1 Clinical Methods: The History, Physical, and Laboratory Examinations [DOI]
2. 2 Clinical Methods: The History, Physical, and Laboratory Examinations [DOI]
3. 3 Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network [DOI]
4. 4 Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries [DOI]
5. 5 Lumbar Puncture in Pediatric Bacterial Meningitis: Defining the Time Interval for Recovery of Cerebrospinal Fluid Pathogens After Parenteral Antibiotic Pretreatment [DOI]
6. 6 Activity of Pleconaril against Enteroviruses [DOI]
7. 7 The Global Impact of Neonatal Infection [DOI]
8. 8 Neonatal Meningitis: What Is the Correlation Among Cerebrospinal Fluid Cultures, Blood Cultures, and Cerebrospinal Fluid Parameters? [DOI]
9. 9 Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases [DOI]
10. 10 Meningitis in infancy in England and Wales: follow up at age 5 years [DOI]
11. 11 Predicting the Outcome of Neonatal Bacterial Meningitis [DOI]
12. 12 Enterovirus 71 infection and vaccines [DOI]
13. 13 Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.
14. 14 Management of Viral Central Nervous System Infections: A Primer for Clinicians [DOI]
15. 15 To Tap or Not to Tap: High Likelihood of Meningitis Without Sepsis Among Very Low Birth Weight Infants [DOI]
16. 16 Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy [DOI]
17. 17 Predictors of neonatal sepsis in developing countries [DOI]
18. 18 Serious bacterial infections in newborn infants in developing countries [DOI]
19. 19 Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis [DOI]
20. 20 Bacterial meningitis in the newborn: A prospective study of mortality and morbidity [DOI]
21. 21 Pleconaril: a novel antipicornaviral drug [DOI]
22. 22 BACTERIAL MENINGITIS AND THE NEWBORN INFANT [DOI]
23. 23 Infantile meningitis in England and Wales: a two year study. [DOI]
24. 24 Neonatal infections in Asia [DOI]
25. 25 Neonatal bacterial meningitis [DOI]
26. 26 Aseptic meningitis: Diagnosis and management [DOI]
27. 27 Long-term Valacyclovir Suppressive Treatment After Herpes Simplex Virus Type 2 Meningitis: A Double-Blind, Randomized Controlled Trial [DOI]
28. 28 Aetiology of neonatal sepsis in Blantyre, Malawi: 1996–2001 [DOI]
29. 29 Meningitis in Preterm Neonates: Importance of Cerebrospinal Fluid Parameters [DOI]
30. 30 Prospective surveillance of neonatal meningitis. [DOI]
31. 31 Herpes Simplex Virus Type 2 as a Cause of Severe Meningitis in Immunocompromised Adults [DOI]
32. 32 Neonatal Meningitis: Can We Do Better? [DOI]
33. 33 Neonatal bacterial meningitis: an update [DOI]
34. 34 Group B streptococcal meningitis: Cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis [DOI]
35. 35 Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples [DOI]
36. 36 Lumbar puncture in the evaluation of suspected neonatal sepsis [DOI]
37. 37 Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia [DOI]
38. 38 The Effect of Lumbar Puncture Position in Sick Neonates [DOI]
39. 39 Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis [DOI]
40. 40 Eleven‐year study of causes of neonatal bacterial meningitis in Ahvaz, Iran [DOI]
41. 41 Treatment of Primary and Recurrent Herpes Simplex Virus Type 2 Induced Meningitis with Acyclovir [DOI]
42. 42 Bacterial meningitis: a review of effective pharmacotherapy [DOI]
43. 43 A history of viral infections of the central nervous system [DOI]
44. 44 Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: Case report [DOI]
45. 45 ADVERSE EFFECTS OF ROUTINE PROCEDURES ON PRETERM INFANTS [DOI]
46. 46 Prospective surveillance of neonatal meningitis. [DOI]
47. 47 Aseptic meningitis in the newborn and young infant.
48. 48 Meningitis in infancy in England and Wales: follow up at age 5 years. [DOI]
49. 49 Candida meningitis: a growing threat to premature and fullterm infants.
50. 50 Cochrane Database of Systematic Reviews [DOI]
51. 51 Current Opinion in Infectious Diseases [DOI]
52. 52 Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study [DOI]
53. 53 Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties [DOI]
54. 54 Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting [DOI]
55. 55 Antiviral Agents [DOI]

Cited by 2

Related research

• Antimicrobial Assessment of Annona muricata Fruits and Its Chemical Compositions — shares topic coverage
• Plasmid Profile of Multidrug Resistant Bacteria Isolated from Wound Swabs from Hospital Patients in Akure, Nigeria — shares topic coverage
• Molecular Detection of Extended Spectrum Beta-lactamase Resistance in Escherichia coli from Poultry Droppings in Keffi, Nigeria — shares topic coverage
• Microbiological Enumeration of Pathogens Associated with Urinary Tract Infection: Current Scenario and Its Medical Relevance — shares topic coverage
• Synergizing Bacteriophage Therapy and Computational Neuroscience: A Ray of Hope in the Fight against Antibiotic Resistance — shares topic coverage